Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
-0.67%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$8.92B
AUM Growth
+$750M
(+9.2%)
Cap. Flow
+$893M
Cap. Flow
% of AUM
10.01%
Top 10 Holdings %
Top 10 Hldgs %
10.22%
Holding
2,098
New
530
Increased
477
Reduced
405
Closed
483
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$127M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 3 |
Microsoft
MSFT
|
+$75.4M |
| 4 |
Visa
V
|
+$64.1M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$62.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$61.6M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$50.4M |
| 5 |
Amgen
AMGN
|
+$46.7M |
Sector Composition
| 1 | Technology | 19% |
| 2 | Industrials | 12.06% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Healthcare | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Embecta
EMBC
$897M
| $337K | ﹤0.01% |
26,923
-16,695
| -38% | -$209K |
|
1277
Accuray
ARAY
$178M
| $336K | ﹤0.01% |
184,597
-2,495
| -1% | -$4.54K |
|
1278
Expeditors International
EXPD
$16.7B
| $335K | ﹤0.01% |
2,682
-41,252
| -94% | -$5.15M |
|
1279
Scholar Rock
SRRK
$3.02B
| $331K | ﹤0.01% |
39,713
+18,847
| +90% | +$157K |
|
|
SQSP
1280
DELISTED
Squarespace, Inc.
SQSP
| $328K | ﹤0.01% |
7,520
-339,485
| -98% | -$14.8M |
|
1281
iShares Core MSCI International Developed Markets ETF
IDEV
$22B
| $327K | ﹤0.01% |
+4,978
| New | +$327K |
|
|
SAGE
1282
DELISTED
Sage Therapeutics
SAGE
| $325K | ﹤0.01% |
29,963
+16,666
| +125% | +$181K |
|
1283
CareDx
CDNA
$732M
| $325K | ﹤0.01% |
+20,926
| New | +$325K |
|
1284
Babcock & Wilcox
BW
$244M
| $323K | ﹤0.01% |
222,928
| – | – |
|
1285
Indivior
INDV
$2.98B
| $322K | ﹤0.01% |
+20,000
| New | +$322K |
|
|
MCHB
1286
Mechanics Bancorp Class A Common Stock
MCHB
$3.06B
| $318K | ﹤0.01% |
27,891
-2,896
| -9% | -$33K |
|
1287
A-Mark Precious Metals
AMRK
$608M
| $317K | ﹤0.01% |
+9,798
| New | +$317K |
|
1288
Moody's
MCO
$92.8B
| $311K | ﹤0.01% |
738
-1,440
| -66% | -$606K |
|
1289
Codexis
CDXS
$221M
| $309K | ﹤0.01% |
+99,686
| New | +$309K |
|
1290
Regenxbio
RGNX
$473M
| $309K | ﹤0.01% |
+26,407
| New | +$309K |
|
1291
OraSure Technologies
OSUR
$242M
| $308K | ﹤0.01% |
72,253
-89,727
| -55% | -$382K |
|
1292
VeriSign
VRSN
$26.9B
| $308K | ﹤0.01% |
+1,731
| New | +$308K |
|
1293
Travere Therapeutics
TVTX
$2.23B
| $306K | ﹤0.01% |
37,283
-103
| -0.3% | -$847 |
|
1294
Brink's
BCO
$4.86B
| $306K | ﹤0.01% |
2,992
-37,379
| -93% | -$3.83M |
|
1295
Opko Health
OPK
$1.14B
| $306K | ﹤0.01% |
244,821
| – | – |
|
1296
OptimizeRx
OPRX
$339M
| $305K | ﹤0.01% |
30,519
-22,463
| -42% | -$225K |
|
1297
Latham Group
SWIM
$936M
| $305K | ﹤0.01% |
100,627
-2,881
| -3% | -$8.73K |
|
1298
4D Molecular Therapeutics
FDMT
$327M
| $304K | ﹤0.01% |
+14,471
| New | +$304K |
|
1299
Southside Bancshares
SBSI
$917M
| $303K | ﹤0.01% |
+10,989
| New | +$303K |
|
1300
CEVA Inc
CEVA
$564M
| $300K | ﹤0.01% |
15,536
-20,409
| -57% | -$394K |
|